Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Benlysta (belimumab) Autoinjector for Children with Systemic Lupus Erythematosus

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg subcutaneous route of administration of Benlysta...

FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Imdelltra™ (tarlatamab-dlle) for the treatment...

Cannabis Use Tied to Higher Risk for Psychotic Disorder in Youth

There is a strong association between cannabis use and risk for psychotic disorder in adolescents, according to a study published online May 22 in Psychological...

Study Identifies Factors That Predict Driving Cessation in Seniors

Among older adults, factors associated with future driving cessation include female sex and neuropsychological measures of cognitive functioning, according...

FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus

The U.S. Food and Drug Administration has approved a 200-mg subcutaneous route of administration of Benlysta (belimumab) for patients 5 years of age and...

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research letter...

Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans

The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023,...

More Americans Now Use Marijuana Each Day Than Alcohol

Reflecting changing times and legislation, Americans are now more apt to light up a joint or pop a weed gummy on a daily basis than they are to raise a...

Scientists Discover Microplastics Abound in Human Testicles

In a finding that suggests microplastics may pose a special danger to men, a new study has shown that human testicles contain these tiny bits of plastic...

Health Savings Could Near $250,000 When Electric School Bus Replaces Diesel

It might be hoped that replacing a diesel school bus with a clean electric model would pay off for health and the environment. New research suggests that...

GSK Announces Positive Results from Phase III Severe Asthma Trials of Depemokimab

GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and...

Zymfentra demonstrated long-term efficacy and safety profile of maintenance treatment for adults with moderately to severely active Crohn's disease and ulcerative colitis

JERSEY CITY, N.J., May 21, 2024. Celltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC)...

Does It Matter What You Eat or Drink Before Bed?

If you suddenly find yourself craving food or drink right before you head to bed, one expert suggests you steer clear of big meals and caffeine. "From...

Cross-Compatibility Issues with Autoinjector Devices Optional for Use with Glatiramer Acetate Injection

FDA is alerting patients, caregivers, and health care professionals of labeling updates for glatiramer acetate injection products. Updated labeling includes...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Imdelltra Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development